Enteropathogen antibody dynamics and force of infection among children in low-resource settings

Little is known about enteropathogen seroepidemiology among children in low-resource settings. We measured serological IgG responses to eight enteropathogens (Giardia intestinalis, Cryptosporidium parvum, Entamoeba histolytica, Salmonella enterica, enterotoxigenic Escherichia coli, Vibrio cholerae, Campylobacter jejuni, norovirus) in cohorts from Haiti, Kenya, and Tanzania. We studied antibody dynamics and force of infection across pathogens and cohorts. Enteropathogens shared common seroepidemiologic features that enabled between-pathogen comparisons of transmission. Overall, exposure was intense: for most pathogens the window of primary infection was <3 years old; for highest transmission pathogens primary infection occurred within the first year. Longitudinal profiles demonstrated significant IgG boosting and waning above seropositivity cutoffs, underscoring the value of longitudinal designs to estimate force of infection. Seroprevalence and force of infection were rank-preserving across pathogens, illustrating the measures provide similar information about transmission heterogeneity. Our findings suggest antibody response can be used to measure population-level transmission of diverse enteropathogens in serologic surveillance.

[1]  J. Lessler,et al.  Estimating cholera incidence with cross-sectional serology , 2019, Science Translational Medicine.

[2]  B. Munoz,et al.  Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities , 2018, Ophthalmic epidemiology.

[3]  J. Vinjé,et al.  Minimally Invasive Saliva Testing to Monitor Norovirus Infection in Community Settings , 2018, The Journal of infectious diseases.

[4]  M. White,et al.  The utility of serology for elimination surveillance of trachoma , 2018, Nature Communications.

[5]  Md Iqbal Hossain,et al.  Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study , 2018, The Lancet. Global health.

[6]  Shannon M Griffin,et al.  Application of a salivary immunoassay in a prospective community study of waterborne infections. , 2018, Water research.

[7]  E. Harris,et al.  Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua , 2018, Proceedings of the National Academy of Sciences.

[8]  Virgilio Gómez-Rubio,et al.  Generalized Additive Models: An Introduction with R (2nd Edition) , 2018 .

[9]  N. Langeland,et al.  Longitudinal cohort study of serum antibody responses towards Giardia lamblia variant-specific surface proteins in a non-endemic area. , 2018, Experimental parasitology.

[10]  R. Wiegand,et al.  Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania , 2018, The American journal of tropical medicine and hygiene.

[11]  Heather M. Scobie,et al.  Integrated Serologic Surveillance of Population Immunity and Disease Transmission , 2018, Emerging infectious diseases.

[12]  D. Cummings,et al.  Reconstruction of antibody dynamics and infection histories to evaluate dengue risk , 2018, Nature.

[13]  D. Gurdasani,et al.  The First Norovirus Longitudinal Seroepidemiological Study From Sub-Saharan Africa Reveals High Seroprevalence of Diverse Genotypes Associated With Host Susceptibility Factors , 2019 .

[14]  R. Haque,et al.  Effects of Water, Sanitation, Handwashing, and Nutritional Interventions on Child Enteric Protozoan Infections in Rural Bangladesh: A Cluster-Randomized Controlled Trial , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Priest,et al.  Giardia and Cryptosporidium antibody prevalence and correlates of exposure among Alaska residents, 2007–2008 , 2018, Epidemiology and Infection.

[16]  D. Sack,et al.  Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers , 2018, PLoS neglected tropical diseases.

[17]  Howard H. Chang,et al.  The impact of school water, sanitation, and hygiene improvements on infectious disease using serum antibody detection , 2018, PLoS neglected tropical diseases.

[18]  Jamae F Morris,et al.  A Randomized Controlled Trial to Assess the Impact of Ceramic Water Filters on Prevention of Diarrhea and Cryptosporidiosis in Infants and Young Children-Western Kenya, 2013. , 2018, The American journal of tropical medicine and hygiene.

[19]  K. Oshima,et al.  Asymptomatic norovirus infection associated with swimming at a tropical beach: A prospective cohort study , 2018, PloS one.

[20]  Ly-Mee Yu,et al.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial , 2017, The Lancet.

[21]  David L. Smith,et al.  Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure , 2017, bioRxiv.

[22]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[23]  T. Clasen,et al.  Use of Serologic Responses against Enteropathogens to Assess the Impact of a Point-of-Use Water Filter: A Randomized Controlled Trial in Western Province, Rwanda. , 2017, The American journal of tropical medicine and hygiene.

[24]  J. Gil,et al.  Serologic Monitoring of Public Health Interventions against Strongyloides stercoralis. , 2017, The American journal of tropical medicine and hygiene.

[25]  J. Cano,et al.  A cross-sectional seroepidemiological survey of typhoid fever in Fiji , 2017, PLoS neglected tropical diseases.

[26]  Mark J van der Laan,et al.  Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels , 2017, bioRxiv.

[27]  Fatima Aziz,et al.  Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study , 2016, The Lancet.

[28]  Shannon M Griffin,et al.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings , 2016, Current Environmental Health Reports.

[29]  C Jessica E Metcalf,et al.  Use of serological surveys to generate key insights into the changing global landscape of infectious disease , 2016, The Lancet.

[30]  G. Kang,et al.  Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Mark A. Miller,et al.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.

[32]  Peter D. Crompton,et al.  Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities , 2015, Proceedings of the National Academy of Sciences.

[33]  D. Graham,et al.  Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. , 2015, The Journal of infectious diseases.

[34]  D. Conway,et al.  Dynamics of the antibody response to Plasmodium falciparum infection in African children. , 2014, The Journal of infectious diseases.

[35]  Aaron A. King,et al.  Time-varying, serotype-specific force of infection of dengue virus , 2014, Proceedings of the National Academy of Sciences.

[36]  J. Priest,et al.  Longitudinal evaluation of enteric protozoa in Haitian children by stool exam and multiplex serologic assay. , 2014, The American journal of tropical medicine and hygiene.

[37]  K. Mølbak,et al.  Serological follow-up after non-typhoid salmonella infection in humans using a mixed lipopolysaccharide ELISA. , 2013, International journal of medical microbiology : IJMM.

[38]  P. Teunis,et al.  Campylobacter seroconversion rates in selected countries in the European Union , 2012, Epidemiology and Infection.

[39]  T. Nutman,et al.  Longitudinal Monitoring of the Development of Antifilarial Antibodies and Acquisition of Wuchereria bancrofti in a Highly Endemic Area of Haiti , 2012, PLoS neglected tropical diseases.

[40]  S. Wood mgcv:Mixed GAM Computation Vehicle with GCV/AIC/REML smoothness estimation , 2012 .

[41]  Y T H P van Duynhoven,et al.  Biomarker dynamics: estimating infection rates from serological data , 2012, Statistics in medicine.

[42]  P. Teunis,et al.  Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases , 2012, BMC Public Health.

[43]  S. Wood,et al.  Coverage Properties of Confidence Intervals for Generalized Additive Model Components , 2012 .

[44]  V. Hytönen,et al.  A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles , 2012, Immunology.

[45]  M. Beach,et al.  Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. , 2011, The American journal of tropical medicine and hygiene.

[46]  Shannon M Griffin,et al.  Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. , 2011, Journal of immunological methods.

[47]  J. Priest,et al.  Multiplex Assay Detection of Immunoglobulin G Antibodies That Recognize Giardia intestinalis and Cryptosporidium parvum Antigens , 2010, Clinical and Vaccine Immunology.

[48]  David R. Hunter,et al.  mixtools: An R Package for Analyzing Mixture Models , 2009 .

[49]  D. Hunter,et al.  mixtools: An R Package for Analyzing Mixture Models , 2009 .

[50]  N Hens,et al.  Seventy-five years of estimating the force of infection from current status data , 2009, Epidemiology and Infection.

[51]  P. Teunis,et al.  Estimation of incidences of infectious diseases based on antibody measurements , 2009, Statistics in medicine.

[52]  C. Siegrist,et al.  B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.

[53]  H. Dupont,et al.  Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. , 2008, Journal of travel medicine.

[54]  Chris Drakeley,et al.  Serology: a robust indicator of malaria transmission intensity? , 2007, Trends in parasitology.

[55]  Feng Chen,et al.  Genomic Minimalism in the Early Diverging Intestinal Parasite Giardia lamblia , 2007, Science.

[56]  P. Teunis,et al.  Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans , 2007, Epidemiology and Infection.

[57]  Alan Y. Chiang,et al.  Generalized Additive Models: An Introduction With R , 2007, Technometrics.

[58]  R. Glass,et al.  Comparing serologic response against enteric pathogens with reported diarrhea to assess the impact of improved household drinking water quality. , 2007, The American journal of tropical medicine and hygiene.

[59]  K. Mølbak,et al.  Kinetics of the Human Antibody Response against Salmonella enterica Serovars Enteritidis and Typhimurium Determined by Lipopolysaccharide Enzyme-Linked Immunosorbent Assay , 2007, Clinical and Vaccine Immunology.

[60]  R. Schmidt-Ott,et al.  Improved serodiagnosis of Campylobacter jejuni infections using recombinant antigens. , 2005, Journal of medical microbiology.

[61]  J. H. Zar,et al.  Spearman Rank Correlation , 2005 .

[62]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Larry Wasserman,et al.  All of Statistics: A Concise Course in Statistical Inference , 2004 .

[64]  Larry Wasserman,et al.  All of Statistics , 2004 .

[65]  J. Montgomery,et al.  DETECTION OF CRYPTOSPORIDIUM ANTIBODIES IN SERA AND ORAL FLUIDS USING MULTIPLEX BEAD ASSAY* , 2004, The Journal of parasitology.

[66]  M. Bienz,et al.  vsp Gene Expression byGiardia lamblia Clone GS/M-83-H7 during Antigenic Variation In Vivo and In Vitro , 2001, Infection and Immunity.

[67]  J. Priest,et al.  Enzyme Immunoassay Detection of Antigen-Specific Immunoglobulin G Antibodies in Longitudinal Serum Samples from Patients with Cryptosporidiosis , 2001, Clinical Diagnostic Laboratory Immunology.

[68]  K. Begtrup,et al.  Antibody Responses to CampylobacterInfections Determined by an Enzyme-Linked Immunosorbent Assay: 2-Year Follow-Up Study of 210 Patients , 2001, Clinical Diagnostic Laboratory Immunology.

[69]  J. Butler Enzyme-Linked Immunosorbent Assay , 2000, Journal of immunoassay.

[70]  J. Priest,et al.  Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. , 2000, Molecular and biochemical parasitology.

[71]  B. Barrell,et al.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences , 2000, Nature.

[72]  J. Priest,et al.  Detection by Enzyme Immunoassay of Serum Immunoglobulin G Antibodies That Recognize SpecificCryptosporidium parvum Antigens , 1999, Journal of Clinical Microbiology.

[73]  N M Ferguson,et al.  Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[74]  J. Roberts,et al.  Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. , 1998, The American journal of tropical medicine and hygiene.

[75]  D. Jasmer,et al.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. , 1996, Molecular and biochemical parasitology.

[76]  J. Nicolet,et al.  Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni , 1995, Journal of clinical microbiology.

[77]  D. Graham,et al.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein , 1992, Journal of virology.

[78]  E. Tannich,et al.  Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[79]  W. Cleveland,et al.  Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .

[80]  M. Levine,et al.  Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology , 1985, Journal of clinical microbiology.

[81]  N. W. Smith,et al.  Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. , 1973, The Journal of infectious diseases.

[82]  Jacob Cohen A Coefficient of Agreement for Nominal Scales , 1960 .

[83]  Ziv Shkedy,et al.  Modeling Infectious Disease Parameters Based on Serological and Social Contact Data , 2012 .

[84]  B. Penninx,et al.  A Randomized Controlled Trial of a Tailored Primary Care Program to Reverse Excessive Alcohol Consumption , 2012, The Journal of the American Board of Family Medicine.

[85]  F. Weill,et al.  WHO Collaborating Centre for Reference and Research on Salmonella ANTIGENIC FORMULAE OF THE SALMONELLA SEROVARS , 2007 .

[86]  M. J. van der Laan,et al.  Statistical Applications in Genetics and Molecular Biology Super Learner , 2010 .

[87]  W. Petri,et al.  Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. , 2004, Vaccine.

[88]  B. Ripley,et al.  Semiparametric Regression: Preface , 2003 .

[89]  David Ruppert,et al.  Semiparametric Regression: Author Index , 2003 .

[90]  Stefan Sperlich,et al.  Generalized Additive Models , 2014 .

[91]  N. Jewell,et al.  Generalizations of current status data with applications , 1995 .

[92]  T. Tajima [Viral gastroenteritis]. , 1994, Nihon rinsho. Japanese journal of clinical medicine.